Figure 5.
Networks of the treatment efficacy and safety of ESA drugs in the treatment of anaemia in chronic kidney disease. Values lower than 1 favour the active treatment in the comparison
Networks of the treatment efficacy and safety of ESA drugs in the treatment of anaemia in chronic kidney disease. Values lower than 1 favour the active treatment in the comparison